Table 2.
Comparison of characteristics between the high SII group and low SII group of patients with iCCA who underwent LT.
| Variables | SII < 447.48 (n = 14) | SII ≥ 447.48 (n = 14) | P value |
|---|---|---|---|
| Gender | P = 0.541 | ||
| Male | 13 (92.9) | 12 (85.7) | |
| Female | 1 (7.1) | 2 (14.3) | |
| Age (years) | 50.0 (45.3-60.0) | 54 (47.8-59.3) | P = 0.380 |
| Child-Pugh Class | P = 0.242 | ||
| A | 4 (28.6) | 3 (21.4) | |
| B | 8 (57.1) | 5 (35.7) | |
| C | 2 (14.3) | 6 (42.9) | |
| BMI | 23.5 (22.4-25.0) | 22.0 (19.9-23.5) | P = 0.423 |
| MELD score | 10 (7-14) | 12 (8-18) | P = 0.592 |
| CEA (μg/L) | 2.6 (1.4-4.2) | 8.2 (3.1-19.3) | P = 0.321 |
| CA19-9 (U/L) | 59.6 (12.0-235.1) | 576.5 (9.2-3874.4) | P = 0.264 |
| AFP (ng/L) | 3.2 (2.6-5.6) | 4.3 (2.8-5.5) | P = 0.624 |
| Tumor number | P = 0.686 | ||
| Single | 10 (71.4) | 9 (64.3) | |
| Multiple | 4 (28.6) | 5 (35.7) | |
| Largest tumor size (cm) | 2.9 (2.0-7.6) | 6.1 (4.3-7.0) | P = 0.428 |
| HBsAg | P = 0.699 | ||
| Positive | 8 (57.1) | 9 (64.3) | |
| Negative | 6 (42.9) | 5 (35.7) | |
| Pretransplant locoregional therapy | 11 (78.6) | 10 (71.4) | P = 0.663 |
| Differentiation | P = 0.329 | ||
| Well | 2 (14.3) | 0 (0.0) | |
| Moderate | 8 (57.1) | 10 (71.4) | |
| Poor | 4 (28.6) | 4 (28.6) | |
| Vascular invasion | 3 (21.4) | 5 (35.7) | P = 0.403 |
| Tumor recurrence | 6 (42.9) | 9 (64.3) | P = 0.256 |
Data are presented as n (%) or median (IQR).